GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 112 filers reported holding GENOMIC HEALTH INC in Q4 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,512,000 | +6.6% | 131,935 | 0.0% | 0.98% | +14.8% |
| Q3 2017 | $4,234,000 | -1.4% | 131,935 | 0.0% | 0.85% | -4.6% |
| Q2 2017 | $4,294,000 | +3.3% | 131,935 | 0.0% | 0.89% | -0.8% |
| Q1 2017 | $4,155,000 | +7.1% | 131,935 | 0.0% | 0.90% | +4.2% |
| Q4 2016 | $3,878,000 | +1.6% | 131,935 | 0.0% | 0.86% | +2.5% |
| Q3 2016 | $3,816,000 | +11.7% | 131,935 | 0.0% | 0.84% | +12.8% |
| Q2 2016 | $3,416,000 | +4.5% | 131,935 | 0.0% | 0.74% | +8.8% |
| Q1 2016 | $3,268,000 | -29.6% | 131,935 | 0.0% | 0.68% | -26.6% |
| Q4 2015 | $4,644,000 | +66.3% | 131,935 | 0.0% | 0.93% | +70.6% |
| Q3 2015 | $2,792,000 | -1.4% | 131,935 | +29.4% | 0.55% | +8.7% |
| Q2 2015 | $2,833,000 | -9.0% | 101,935 | 0.0% | 0.50% | -8.2% |
| Q1 2015 | $3,114,000 | +35.4% | 101,935 | +41.7% | 0.55% | +26.9% |
| Q4 2014 | $2,300,000 | +101.9% | 71,935 | +98.8% | 0.43% | +83.1% |
| Q3 2014 | $1,139,000 | – | 36,179 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |